CATO Q4 2025 Earnings Loss of 055 per Share Amid Challenging Retail Environment MNR Q1 2026 Earnings Significant EPS Miss Amid Challenging Environment Dianthus Therapeutics Q1 2026 Earnings EPS Beat Driven by Cost Discipline Yet Shares Slip Teradyne Q1 2026 Earnings Strong EPS Beat Driven by Robust Demand in Semiconductor Test JOBY Q1 2026 Earnings EPS Beat by 39 Highlights Progress in eVTOL Development Path ETOR Q1 2026 Earnings EPS Surges Past Estimates by 234 Revenue Details Remain Undisclosed